Personal information
Biography
Dr. Li completed his MD, 1982, and PhD, 1987, in China, a postdoctoral fellowship at the University of Saskatchewan and a fellowship at Harvard Medical School. After finished a clinical residency in Psychiatry, he served as the Director of the Neuropsychiatry Research Unit from 2000 to 2007, before moved to the University of Manitoba as Professor and Ruth Hurd Research Chair, Medical Director of the International Medical Graduate Program, Director of the Neuroscience Research Program and Assistant Dean, International Medical Education. In 2013, he joined the University of Alberta, as Chair of Psychiatry; AHS Chair in Mental Health Research. From 2020, he serves as Associate Dean, International Relations. In 2022, He was elected as a fellow of Canadian Academy of Health Sciences.
Dr. Xin-Min Li is an academic psychiatrist and clinician scientist who has pioneered work on the protective function of antipsychotics on brain white matter changes observed in schizophrenia and depression and is exploring innovative use of cerebral low field magnetic stimulation and ultrasound for treatment resistant depression. Dr. Li continues to provide leadership in academic health sciences training of clinician scientists and allied research scientists and is currently leading international academic health program development and partnerships for the Faculty of Medicine and Dentistry at the University of Alberta.